Arcutis Biotherapeutics, Inc.
ARQT· Nasdaq
ARQTArcutis Biotherapeutics, Inc.
Filed Feb 16, 2021 · 10-K · 47 days after period end · 0001628280-21-002272
| Metric | Q4 2020 | Q4 2019 |
|---|---|---|
| Net Income | -$34.05M | -$12.57M |
| EPS Diluted | -$0.79 | -$6.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcutis Biotherapeutics, Inc. · CIK 1787306 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 16, 2021 · 47 d after period end
